. Author manuscript; available in PMC: 2013 Feb 28.

Published in final edited form as: J Urol. 2011 Feb 22;185(4):1268–1273. doi: 10.1016/j.juro.2010.11.089

Table 3.

Statin use and recurrence after prostatectomy in 1,583 men (74%) who responded to survey in Johns Hopkins Hospital prostatectomy cohort from 1993 to 2006

Time Dependent Statin Use	No. Recurrences/No. Person-Years	Adjusted HR (95% CI)^*
Never	86/7,266	1.00 (referent)
Ever (yrs):	41/3,889	0.99 (0.64–1.55)
Less than 1	7/445	2.42 (0.94–6.24)
1 or Greater	27/3,444	0.77 (0.41–1.42)

Adjusted for age (years, continuous), race (black, white or other/missing), BMI (less than 25, 25 to less than 30, 30 kg/m² or greater, or missing), smoking (never, current, former or missing), prostate cancer family history (no, yes or missing), aspirin use (no or yes), and ACE inhibitor use (no or yes) at prostatectomy, surgery calendar year (continuous), preoperative PSA (continuous), pathological stage (nonorgan confined or organ confined disease) and Gleason sum (less than 4 + 3, or 4 + 3 or greater).